--- title: "Organigram (TSE:OGI) Stock Price Down 0.4% - Here's Why" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/224851378.md" description: "Organigram Holdings Inc. (TSE:OGI) saw a 0.4% decline in stock price, trading at C$2.26 after reaching a low of C$2.18. The trading volume was down 22% from the average. Analysts have lowered price targets, with Canaccord Genuity reducing theirs from C$3.60 to C$3.15, and ATB Capital from C$5.25 to C$3.50. The company has a market cap of C$245.37 million and a P/E ratio of -0.90. Insider Paolo De Luca sold 12,014 shares at C$2.52. Organigram specializes in cannabis production and sales in Canada." datetime: "2025-01-14T05:52:36.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/224851378.md) - [en](https://longbridge.com/en/news/224851378.md) - [zh-HK](https://longbridge.com/zh-HK/news/224851378.md) --- > 支持的语言: [English](https://longbridge.com/en/news/224851378.md) | [繁體中文](https://longbridge.com/zh-HK/news/224851378.md) # Organigram (TSE:OGI) Stock Price Down 0.4% - Here's Why Organigram Holdings Inc. (TSE:OGI - Get Free Report) fell 0.4% during trading on Monday . The stock traded as low as C$2.18 and last traded at C$2.26. 174,291 shares changed hands during mid-day trading, a decline of 22% from the average session volume of 223,412 shares. The stock had previously closed at C$2.27. ## Analyst Ratings Changes Several equities research analysts have recently weighed in on the company. Canaccord Genuity Group reduced their price objective on Organigram from C$3.60 to C$3.15 and set a "speculative buy" rating for the company in a research report on Monday, December 9th. ATB Capital dropped their price objective on shares of Organigram from C$5.25 to C$3.50 in a report on Tuesday, December 17th. **View Our Latest Stock Analysis on Organigram** ## Organigram Trading Down 0.4 % The company has a current ratio of 6.95, a quick ratio of 2.62 and a debt-to-equity ratio of 1.13. The stock has a market cap of C$245.37 million, a P/E ratio of -0.90, a price-to-earnings-growth ratio of 0.42 and a beta of 1.13. The business's fifty day simple moving average is C$2.21 and its 200 day simple moving average is C$2.32. ## Insider Activity In other news, Senior Officer Paolo De Luca sold 12,014 shares of the firm's stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of C$2.52, for a total value of C$30,275.28. 31.32% of the stock is owned by insiders. ## Organigram Company Profile (Get Free Report) Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands. ## Recommended Stories - Five stocks we like better than Organigram - What is the Dow Jones Industrial Average (DJIA)? - 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports - 3 Natural Gas Stocks That Offer Great Dividend Yields - Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025 - What is a SEC Filing? - Delta Can Fly to New Highs in 2025; Here’s Why _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in Organigram Right Now? Before you consider Organigram, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram wasn't on the list. While Organigram currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### 相关股票 - [Organigram (OGI.US)](https://longbridge.com/zh-CN/quote/OGI.US.md) ## 相关资讯与研究 - [Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting | OGI Stock News](https://longbridge.com/zh-CN/news/281093684.md) - [OrganiGram Global Inc. Releases MD&A for Three Months Ended December 31, 2025](https://longbridge.com/zh-CN/news/275459685.md) - [OrganiGram Global Inc. steigert im ersten Quartal das bereinigte EBITDA auf 5,27 Mio. CAD, ein Plus um das 3,7-Fache](https://longbridge.com/zh-CN/news/275444292.md) - [OrganiGram Global Inc. veröffentlicht MD&A-Bericht für das erste Quartal 2026](https://longbridge.com/zh-CN/news/275459714.md) - [Canadian cannabis firm Organigram's Q1 net revenue jumps 49%](https://longbridge.com/zh-CN/news/275445671.md)